Organon & Co. (Pharmaceutical Preparations)

Pharmaceutical Preparations

Filing Clarity monitors every SEC filing for Organon & Co. — Form 4 insider transactions, 8-K material events, and quarterly reports — and delivers plain-English signals with historical context.

Recent SEC filing signals

Filing Clarity delivers plain-English signals for each new filing, with historical context showing what changed from prior periods.

Earnings SynthesisOrganon & Co. Q4-2024: "bookends" First appearance; used to describe 2025 quarterly revenue cadence (lowest in Q1, hi…2026-08-17

Earnings SynthesisOrganon & Co. Q1-2025: "deleveraging" Increased frequency; central theme of call versus prior discussion2026-08-17

Earnings SynthesisOrganon & Co. Q3-2025: "making tangible progress" Consistent frequency across last four quarters2026-08-17

Earnings SynthesisOrganon & Co. Q4-2025: "making disciplined progress" Consistent with Q4-2025 language, appearing for third consecutiv…2026-08-17

Ecosystem

Bayer (competitor)Pfizer (competitor)Johnson & Johnson (competitor)Novartis (competitor)AbbVie (competitor)Merck & Co. (competitor)

Monitor OGN with Filing Clarity

Plain-English signals for every OGN SEC filing. Free during our testing period — no credit card required.

Add OGN to my watchlist →

What is an 8-K? How to read Form 4 Pricing